{"id":214519,"title":"Archived 35: Summary of NACI statement of March 17, 2022:  Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:51:23.984000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age/summary-march-17-2022.html?wbdisable=false","snippet":"Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating it. You can…","rawSnapshotUrl":"/api/snapshots/raw/214519","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185123/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-11-years-age/summary-march-17-2022.html?wbdisable=false#ha_snapshot=214519","mimeType":"text/html","statusCode":200}